LIKE RIGHT WING EXTREMISTS GARDASIL AND CERVARIX NEED TO BE STOPPED IN THEIR TRACKS.
By Barbara Loe Fisher
If you are a resident of Washington state, you should know that there is a bill quietly sailing through your state legislature that violates your privacy and threatens your right to make informed, voluntary decisions about vaccination. House Bill 1015 1 and Senate Bill 5005 also discriminates against parents by failing to give them equal protection under the federal National Childhood Vaccine Injury Act of 1986 (PL 99-660). 2
New Law Threatens Informed Consent Rights and Violates First Amendment
The proposed new law will legally require doctors and nurses to personally sign off on all religious or personal belief exemptions to vaccination filed with the state. Parents seeking non-medical exemptions will be required to include a signature from a vaccine provider on the exemption form stating that they have been given vaccine benefit and risk information. 3 Currently Washington state mandatory vaccination laws 4 only require signatures from medical personnel when medical exemptions are filed.
If this bill becomes law, it will put doctors, nurses and other medical personnel in the legal position of acting as inquisitors of religious beliefs held by fellow citizens, which is an invasion of privacy and a de facto violation of First Amendment rights. 5 Americans associated with the medical profession will have the power to sit in judgment of, or interfere with, the free exercise of religious, spiritual or conscientious beliefs of other Americans. It will also make it easier for doctors to punish parents making selective vaccine choices by denying their children medical care, which is the official policy of many U.S. pediatricians. 6 The ethical principle of informed consent 7 to medical risk taking means that you, as an individual or the legal guardian of an individual, have the human right to be fully informed about the benefits and risks of a medical intervention and make a voluntary decision without being harassed or coerced by anyone. 8 The informed consent principle protects individuals in every society from exploitation by those in positions of power in medicine, government and industry. 9, 10, 11 The proposed Washington state bill makes it easier for doctors and other medical personnel to violate an individual's informed consent rights and discriminate against those filing vaccine exemptions, who may hold different beliefs and values. 12, 13, 14, 15 Informed consent is especially important when it comes to vaccination because doctors and nurses cannot predict ahead of time who will be injured by vaccines. More than $2 billion dollars has been awarded by the U.S. Court of Claims 16 to compensate vaccine victims, mostly children, whose doctors did not know they would suffer brain inflammation, immune dysregulation and become permanently disabled or even die after vaccination. 17, 18, 19 Bill Also Ignores Federal Law Requirements
Co-sponsors of the new Washington state vaccine law do not acknowledge in the bill that there is already a federal law in place since 1986, 20, 21 which legally requires doctors, nurses and all vaccine providers to:
1. Give parents vaccine benefit and risk information before vaccination takes place; Record serious health problems, including hospitalizations, injuries and deaths, after vaccination in the child's permanent medical records;
2. Report serious health problems after vaccination 22 to the federal Vaccine Adverse Events Reporting System (VAERS) 23 3. Keep a permanent record of all vaccines given, including the manufacturer's name and lot number.
Unfortunately, today most vaccine providers do not obey these important federal law requirements. So if the goal of the new law is to educate parents about vaccination, it should simply state that all vaccine providers are legally required to give every parent Vaccine Information Statements (VIS) produced by the Centers for Disease Control, 24 which also contain information about reporting vaccine reactions and the federal vaccine injury
compensation program.
Protect Your Rights. Take Action TODAY!If you are a Washington State resident and do not want to lose your right to file a religious or personal belief exemption to vaccination without getting the signature of a doctor or nurse, you need take action TODAY.
Sign up for NVIC's Advocacy Portal and learn how to take action and make your voice heard. No matter what state you live in, please join forces now with the oldest, largest, and most experienced vaccine safety and informed consent organization, the non-profit National Vaccine Information Center, 25, 26 and fight for your freedom to make voluntary vaccine choices in America. If it can happen in Washington state, it can happen in your state. Defend your informed consent rights.
Please forward the public service announcement linked to the end of this commentary to everyone you know about how to join NVIC's Advocacy Portal.
It's your health. Your family. Your choice.
Click here to watch NVIC's Advocacy Portal Public Service Announcement.
References
The National Childhood Vaccine Injury Act of 1986 (PL 99-660). Subpart C - Assuring a Safer Childhood Vaccination Program in the United States (300 aa 25-28): Recording and reporting of information; vaccine information; mandate for safer childhood vaccines; manufacturer recordkeeping and reporting. Washington State House of Representatives, Office of Program Research. Bill Analysis (HB1015) Health Care & Wellness Committee. January 11, 2011. University of Washington School of Medicine. Ethics in Medicine: Informed Consent. Evans G, Bostrom A, Johnston RB, Fisher BL, Stoto MA, editors. Risk Communication and Vaccination: Summary of a Workshop. Institute of Medicine, National Academies Press 1997. U.S. Department of Health & Human Services. Vaccine Adverse Events Reporting System (VAERS). National Vaccine Information Center. About Us.
The following letter was sent to the UK Health Team and various members of Parliament by the Secretary of SaneVax Inc., Freda Birrell, on behalf of the HPV vaccine injured throughout the United Kingdom:
GARDASIL VERSUS CERVARIX
THIS IS A LOT LIKE ASKING: "DO YOU PREFER HEMLOCK OR CYANIDE!
Doctors call for teenage girls to be given STD vaccine
Kiran Randhawa, Health and Social Affairs Correspondent
14 Feb 2011
Doctors today called on the Government to introduce a vaccine for girls on the NHS against genital warts, after infection rates soared.
New figures show cases of the human papillomavirus, which can also lead to cervical cancer, have risen by a third in a decade to 91,000 – with 14,000 in London, the worst-hit area.
It is the second most common sexually transmitted disease after chlamydia and the NHS spends at least £46million a year treating the infection, plus a further £4million on other conditions it causes.
The current HPV vaccine, Cervarix, introduced for all girls aged 13 to 18 in 2008, prevents against the strains that cause cervical cancer, but leaves young women at risk of developing genital warts.
Now 500 doctors and other sexual health workers are backing a campaign by the British Association for Sexual Health and HIV to get the jab replaced with Gardasil, which protects against both conditions.
Please note the above colored words are incorrect – HPV is not a sexually transmitted disease but is a virus which can leave the body of its own accord without causing any harm.
Pap screening has saved more lives from Cervical Cancer. There is no evidence as yet that either Gardasil or Cervarix will do the same and it is recommended that this screening process has to continue even although the subjects have been vaccinated.
THE FACTS:
Information received from Dr Diane Harper, Principal Researcher with Merck on Gardasil on 18th February 2011. We asked the question about the length of protection that Gardasil would provide for genital warts. This is her answer:
“Yes, the data for Gardasil protecting against genital warts in BOYS only goes out to 29 months (2+ years). They did not study whether the efficacy lasts any longer than the 29 months.”
This will apply also to girls otherwise Dr Harper would have made reference to any studies which had been specifically carried out on females.
Duration of Protection for Gardasil: At this moment in time 5 years. Therefore, those who were vaccinated early in the programme in 2006, their protection period will soon be running out.
All of these facts can be quite easily checked out and the question is “Is this really what we want to provide for our girls in the UK?”
MEMORIAL DOCUMENT – GARDASIL
Please see the photographs and stories of girls who have died following vaccination with Gardasil. This is the common link to all of them and also to the complete list of girls who died following vaccination. The disturbing point is that in many cases after post-mortem no known cause of death was identified. When the medical histories of the girls are examined it is apparent to the families that something is seriously wrong as their daughters were very healthy, in a lot of cases very athletic and for whatever reason their lives were cut short not long after they received this HPV vaccine.
Girls who have died following Gardasil come from many States in America, from Canada, from India and from New Zealand. The reports in VAERS only represent between 1% and 10% of those which have been reported therefore there is a huge discrepancy and the undernoted figures could be enormous.
This entry was written by admin, posted on February 26, 2011 at 11:22 pm, filed under Cervarix,Gardasil/Silgard, Government Agencies, Scotland and tagged adverse reactions, cervarix, Gardasil, HPV vaccines, Parliament. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.
The FDA adverse event reports on the HPV vaccine read like a catalog of horrors. Any state or local government now beset by Merck’s lobbying campaigns to mandate this HPV vaccine for young girls ought to take a look at these adverse health reports."
-Tom Fitton
On June 8, 2006, the Food and Drug Administration (FDA) approved the drug Gardasil. Gardasil is a vaccine against certain types of human papillomavirus (HPV) which is the primary cause of cervical cancer in women.
- Several state and local governments have proposed requiring the vaccine for school girls entering the 6th grade.
- Gardasil is approved for girls as young as nine years old, despite the fact that the youngest girls participating in clinical trials were 11-12 years old.
- A recent study, published in the New England Journal of Medicine, also questioned the general effectiveness of Gardasil. Additionally, there has not been a chance to study long term side effects of the vaccine.
Judicial Watch, concerned about the rush to market and mandate a drug with possible serious adverse effects, filed its first Freedom of Information Act (FOIA) request on May 9, 2007, and received 1,637 adverse event reports on May 15, 2007. These reports are submitted to the Vaccine Adverse Event Reporting System (VAERS) and used by the FDA to monitor the safety of vaccines.
On August 20, 2007 Judicial Watch filed a request for updated adverse event reports and received 1,824 reports on September, 13 2007. Judicial Watch then filed a complaint against the FDA on October 3, 2007 for failing to fully respond to the May 9, 2007 FOIA request.
Judicial Watch has posted links to the adverse event reports below and continues to monitor VAERS reports submitted to the FDA in relation to Gardasil.
The case was closed in April 2010.
Special Reports
Documents Uncovered
- Vaccine Adverse Effects Report System (VAERS) serious effects report from May, 2009 to September, 2010 - September 28, 2010
- Vaccine Adverse Effects Report System (VAERS) cumulative deaths report - June 16, 2009
- Vaccine Adverse Effects Report System (VAERS) serious effects report from May 1, 2008 to May 15, 2009- May 15, 2009
- Vaccine Adverse Effects Report System (VAERS) serious effects report from January 1, 2008 to June 10, 2008 - June 30, 2008
- Vaccine Adverse Effects Report System (VAERS) cumulative deaths report - June 30, 2008
- Vaccine Adverse Effects Report System (VAERS) reports on Guillane-Barre Syndrome, spontaneous abortions, and all life-threatening cases from 2008 - June 30, 2008
- Vaccine Adverse Effects Report System (VAERS) cumulative Gardasil adverse effects report (Warning, this is a very large file) - June 30, 2008
- Merck's application to the FDA to patent the Gardasil vaccine - February 22, 2008
- Merck's standard Gardasil information publication
- Merck's report to the FDA giving the details of Gardasil and its clinical test results - February 22, 2008
- A transcript of the Vaccines and Related Biological Products Advisory Committee's meeting to discuss Gardasil - February 22, 2008
- Document from the FDA giving a determination of Regulatory Review Period for Purposes of Patent Extension for Gardasil - February 22, 2008
- Gardasil Related Deaths Reported to VAERS as of September 7, 2007
- Gardasil Related Deaths Reported to VAERS as of May 11, 2007
- Vaccine Adverse Event Reporting System (VAERS) Reports as of September 7, 2007
- Vaccine Adverse Event Reporting System (VAERS) Reports as of May 11, 2007
Litigation Documents
Press Releases
News Stories, Reports and Informational Links
New England Journal of Medicine
The Natural Solutions Foundation works hard to keep you posted on all health freedom issues. There is nowhere else you can so for such wide ranging, objective and clear information on all of the health freedom assaults. When you make a recurring donation, you become eligible to join the Health Freedom Heroes Forum! Become part of the inner circle and help make strategic decisions on the focus and activities of health freedom at home and abroad.
Thanks for your support! Remember, disseminate, disseminate, disseminate!
RICHMOND
The House of Delegates passed legislation today that would revoke Virginia's mandatory human papillomavirus vaccination for young girls.
The vote came after vigorous, sometimes emotional debate dominated by the House's women and doctors. Both groups were divided on the issue.
Virginia mandated the vaccine in 2007, becoming the only state so far to do so. The series of three shots protects against a sexually transmitted virus that is the leading cause of cervical cancer.
Under the law, girls must receive the first dose of the vaccine before they enter the sixth grade.
The law contains an opt-out provision allowing a child to be exempted from the requirement once her parent or guardian has reviewed materials describing the link between HPV and cancer.
That's not good enough for Del. Kathy Byron, R-Campbell County, whose bill, HB1419, would revoke the mandate entirely.
In floor debate Thursday, Byron reminded her colleagues that the manufacturers of the vaccine lobbied heavily for the 2007 law. She also noted that there have been reports of seizures and other adverse reactions, including deaths, among girls who received the shots.
On a more fundamental level, Byron cast the issue as one of governmental intrusion on personal liberty.
"It's a decision that shouldn't be made by the state," she said. "It should be made by parents."
Del. Jeion Ward, D-Hampton, a co-patron of the 2007 law, urged the House to keep the mandate intact. "This vaccine will save lives," she said.
Del. Paula Miller, D-Norfolk, called the 2007 law "an insurance policy against a dreaded disease. We do our daughters a great disservice if you undo it."
She said most of the reported adverse reactions to the shots were minor and that no reported deaths have been definitively linked to the vaccine.
Her 17-year-old daughter has had the vaccine, Miller said, and "I can sleep peacefully at night knowing I have taken steps to protect her against at least one deadly virus."
The House's three doctors were similarly split.
"It's a wonderful vaccine," said Del. John O'Bannon, R-Henrico County, a neurologist. But, he added, he is philosophically opposed to mandating it.
"This is not a panacea," said Del. Scott Garrett, R-Lynchburg, a surgeon. He argued that, because some cases of cervical cancer come from other causes, the vaccine might give women a false sense of security.
Del. Chris Stolle, R-Virginia Beach, an obstetrician/gynecologist, called the vaccine a "lifesaving intervention" that could prevent 1,300 deaths a year. Mandating it is key to its success, he said, because it is necessary to vaccinate a large percentage of the population to stop the spread of the disease.
"If we were all monogamous or abstinent, there would be no need for it," Stolle said. "But that is not the world we live in."
Byron's bill was approved 61-33 by the Republican-controlled House, largely along party lines. Stolle was the only Republican to vote against it. The measure now advances to the Democrat-controlled Senate, where its fate is uncertain.
Bill Sizemore, (804) 697-1560, bill.sizemore@pilotonline.com
Scottish politicians seek answers as cervical cancer vaccine fears grow.
THE Scottish Government has been challenged to explain why it introduced the cervical cancer vaccination program in a series of questions by MSPs.
Freda Birell, of ICAP, raised concerns about inadequate research, incorrect data presented to parents, and serious illnesses being reported from girls who have received Cervarix.
The Scotsman revealed more than 150 girls in Scotland have suffered adverse reactions after receiving the vaccine, introduced last autumn.
The story led a number of MSPs to look into the vaccination programme and ask whether enough research had been carried out before Cervarix was introduced. Mrs Scanlon has taken up ICAP's concerns and has asked the government:
• How old were women involved in the clinical trials of the vaccine?
• What measures were taken to establish whether young women already have HPV prior to the administration of the vaccine?
• How long were the clinical trials of the vaccine?
Freda Birrell's MSP….told The Scotsman: "The questions Mary raised cover immediate issues we'd like clarification on. We want to understand the way the government is pushing ahead with the vaccination programme and want more background information on detailed concerns.
"When anyone raises questions, it would be sensible for the government to be as open as possible and be helpful on why the government decided to introduce the programme."
Ms Robison: "While each (adverse) reaction is thoroughly investigated, it is also very important to put this figure into the appropriate context. According to initial figures, almost 64,000 girls in school – 92 per cent of those eligible – received their first dose of the HPV vaccine last year. If 150 of these girls experienced adverse events, this would amount to 0.2 per cent of those immunised."
The response has angered campaigners and parents who believe their daughters are experiencing serious side-effects after being vaccinated.
They claim many adverse reactions will not have been reported and that potentially serious side-effects are being downplayed.
"There are serious errors in the published factsheet about side-effects. The figures were understated by two decimal places – and some common side-effects such as arthralgia were not even mentioned.
"Why would the Dept of Health not wish to inform GPs, the schools or the general public that the risks of side-effects are 10-100 times greater than they originally stated?
"Would the public consider this a fraudulent act – a total deception, incompetence or negligence?"
GIRL, 13, UNABLE TO GO TO SCHOOL SINCE MARCH
Clare Ramagge, a mother from Surrey, had to give up work to become a full-time carer for 13yrs Rebecca, who can't get up, walk or go to the toilet without help and hasn't been to school since March. She suffers dizziness, chronic fatigue, aching muscles, sight problems and nausea on a daily basis – problems she hadn't experienced until the vaccination, of three Cervarix jabs.
3 Scottish parents have been in touch since The Scotsman reported on Cervarix's , all believe their daughters' conditions are linked to the vaccination.
In one case, a previously active 16-year old suffered extreme lethargy, sore throats, flu-like symptoms, loss of voice, loss of appetite, lack of enthusiasm for any leisure pastime, painful muscles and swollen glands. Her doctor initially said it was a "viral infection", and then fainting episodes began leaving her unconscious for up to 90 minutes. The girl has also had fits.
Another Scottish mother whose daughter has suffered tingling, heaviness and fever, sickness, abdominal pains, dizziness and sight problems, failed to report the side-effects because she didn't know how.
FORTUNE -- There's a liquid drug that women can get injected into a layer of muscle -- three separate times over a six-month period -- that can protect them from a kind of cancer. From a scientific perspective, that's amazing. In terms of public health, it's a breakthrough.
But four years after Merck (MRK, Fortune 500) released this would-be top-seller, called Gardasil, it has proven to be a marketplace dud. In Merck's second quarter, the company reported an 18% year-over-year drop in sales to $219 million and its stock is down nearly 3% to date. Analysts are pointing to Gardasil not as a savior, but as a risk for investors.
What happened?
The answer is complicated and carries lessons for both drug makers and investors. Gardasil ran into two major roadblocks: consumer inertia and politics. The science, and market demand -- two areas that have tripped up drug makers in the past -- weren't issues. "The awareness went out pretty quickly as to what this was and what they accomplished," says Bert Hazlett, an analyst at BMO Capital Markets.
First, the science: human papilloma virus, or HPV, is an incredibly common sexually transmitted disease. There are over 100 different strains of the virus, most of which the body can fight off without any symptoms. But some it can't. Two of these strains cause about 70% of cervical cancers in women.
In 1991, a student of the German scientist who won a Nobel for linking HPV and cervical cancer started working with a partner to get an HPV vaccine they'd developed to market. Merck and GlaxoSmithKline (GSK) bit. Merck's Gardasil protected women against four high-risk strains of HPV. It hit the market in 2006, before GlaxoSmithKline could come out with a similar product, called Cervarix, three years later.
Analysts predicted that Gardasil would take off. And it did. Briefly. Gardasil grossed over $1.1 billion within nine months of hitting the market, Merck had distributed 13 million doses of the vaccine, and it had been approved in 86 countries.
And that was the end of the rocket ride. Since then, Gardasil sales have been flat or declining, with analysts expecting the drug to pull in $1 billion in sales for years to come. That kind of annuity may be fine in some industries, but drug makers need big hits to make up for lab disappointments.
The main problem with Gardasil seems to be the equivalent of a design flaw. To be completely immunized, women have to get a series of three shots over six months. Many women don't.
An analyst brought up the issue of following through with the shot series during the 2007 third quarter report. Merck CEO Dick Clark said that the company was addressing the problem:
"We have put in place substantial reminder programs that allow them to improve the ability to remember to go back to the second and third dose. So, we're doing it by mail, we're doing it by e-mail, we're doing it by text messages, and a variety of different technologies to be able to make sure [that] they get to their second, and third doses."
Turns out, drug reminders don't work well in a technology better suited for LOL. The Centers for Disease Control reported in late August that while 44% of teenagers received the HPV vaccine in 2009, only 27% of them received all three doses of the shot. Unfortunately, there isn't evidence to support that getting only one shot effectively protects against cancer. So why aren't women finishing the series?
1) People are spending less on medicine in general.
The growth rate of annual spending per person on health care in the United States has decreased since 2004, according to the Bureau of Economic Analysis. Three shots of Gardasil cost just under $400 dollars, about three to four times as much as MMR booster shots. Because children aren't required to get Gardasil for school, like MMR vaccines, parents can opt out.
2) Some parents aren't comfortable vaccinating young children against a virus they can only get from having sex.
In 2007, when Texas governor Rick Perry issued an executive order that all girls entering the 6th grade would receive Gardasil, parents were furious. Some argued that the vaccine would promote promiscuity. The order was eventually overturned.
3) Merck didn't properly prepare the right doctors.
When Gardasil came out, Merck marketed it to college-age women. This meant that physicians talking to patients about Gardasil were typically gynecologists, not pediatricians. "When you think about those OBGYNs who tend to be the primary physicians for the 19-26 year old group, they're not vaccinators," says Anthony Butler, a pharmaceutical analyst at Barclays.
4) Merck couldn't counter the bad press.
In 2008, the New York Post published an article about a woman whose daughter died after getting the series of shots. No one linked Gardasil to the cause of death, but the drug was launched into the fierce debate over vaccine safety. Large public health organizations still see a future for the drug. Now, the American College of Obstetricians and Gynecologists has supported vaccinating younger girls, down to age 11 and 12. The CDC says the drug is safe and effective and doing well - from a health point of view, if not a financial one. "HPV vaccine uptake is similar or better than that of other adolescent vaccines in the first few years after vaccine introduction," said Dr. Lauri Markowitz, an HPV expert at the CDC.
Merck is still pushing into other markets. The company is looking for approval of Gardasil in women of different age groups, and got the drug approved in 2009 for use in men, to prevent them from carrying cancer-causing strains or getting genital warts caused by HPV. The company has also just signed a deal with Chinese pharmaceutical company Sinopharm to try to sell products, including an HPV vaccine, in China.
But a full comeback seems unlikely. "Unjustified fears have affected the product," says Hazlett, "and they are fighting a tough battle to reinvigorate the franchise. From an investment perspective, we're not really banking on something like that happening."
Gardasil now faces competition from GSK's Cervarix, which was approved in 2009. If that drug, which also requires a three-shot regimen, penetrates the market in a way that Gardasil couldn't, then perhaps bad timing and bad press are to blame. But if Cervarix falters, then the problem could be that treatment requires multiple shots. Or, maybe people just aren't ready for a cancer vaccine when it's for a sexually transmitted disease.
The headlines alone tell the whole story. ‘Teenage girl left brain-damaged after receiving cervical cancer jab‘, ‘Thousands of UK schoolgirls have suffered adverse reactions…several reported multiple reactions’, ‘20,575 adverse reactions, 352 reports of abnormal pap smears post vaccination, 89 reported deaths’, ‘New Worries About Gardasil Safety’, ‘Cervical Cancer Vaccine May Raise Risk of Guillain-Barre Syndrome’, ‘8 more deaths connected to HPV vaccine’…
According to the Centre for Disease Control (CDC), Cervical Cancer is “the 2nd leading cause of cancer deaths among women around the world. In the United States, about 10,000 women get cervical cancer every year and about 4,000 are expected to die from it.”. What the CDC doesn’t tell you is the fact that “70 percent of all HPV infections resolve themselves without treatment within a year. Within two years, the number climbs to 90 percent. Of the remaining 10 percent of HPV infections, only half will develop into cervical cancer, which leaves little need for the vaccine” – the viewpoint of Dr.Diane Harper, lead researcher in the development of two human papilloma virus vaccines, Gardasil and Cervarix, and one seemingly in direct contradiction to the scientific literature being ‘foisted’ on the public by Vaccine Manufacturers Merck (Gardasil) & GlaxoSmithKline (Cervarix); vigorously backed by Government directed Health Departments around the world.
In fact, Merck clearly admits, on its package inset, to the limited effectiveness of its product – ‘GARDASIL has not been demonstrated to protect against diseases due to HPV types not contained in the vaccine. Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL protects only against those vulvar, vaginal, and anal cancers caused by HPV (Human Papillomavirus).’
Gardasil ostensibly protects against 4 of the most prevalent genital HPV strains, types 6, 11, 16 & 18; said to account for 70% of cervical cancers & 90% of related genital warts. Given the limitations of Merck’s original clinical trial methods, the fact that malignant cervical cancer takes decades to develop and yet the longest clinical trial on Gardasil was only four years in duration; irrespective of the overwhelming evidence citing a 74% drop in cervical cancer mortality & incidence rates, in developed countries, due to a widespread emphasis on regular pap smears & safe sex and/or abstinence from unprotected sex, the bottom line indicates ‘Gardasil was never shown to prevent cervical cancer.’
The official tally of serious adverse events (ie. Guillain-Barre Syndrome) & deaths resulting from inoculation with Gardasil & Cervarix currently stands at ‘3.34/100,000 doses distributed’, almost double the average death rate from cervical cancer (2.4/100,000 women). The Vaccine Adverse Event Reporting System (VAERS) has confirmed, as of November 3, 2010, a total of 20,575 adverse reactions, including 352 reports of abnormal pap smears post vaccination and 89 reported deaths associated with Gardasil & Cervarix.
Studies conducted by the CDC (Vaers is sponsored & overseen by the CDC) have been shown to miss from 10% to 90% of the actual cases because of under-reporting. Hospitals are trained/inclined to ignore associating the vaccine when investigating such complaints; shifting the blame instead to outside factors such as a pre-existing medical condition or compromised immune system – anything but the shot itself. The CDC only recommends monitoring for ‘15 minutes after vaccination to avoid potential injury from a fall.’ Neurological & neuro-developmental related side effects to vaccines can take time to manifest, depending on the individual; in some cases days or weeks after the injection. This is a tactic frequently used by Vaccine Manufacturers to avoid liability in Vaccine Court. Therefore given the uncertainty of accuracy based on these figures, the true number reflecting actual adverse reactions to the HPV Vaccine series could range anywhere from 25-40,000 cases.
‘The fact is that malignant cervical cancer takes decades to develop and yet the longest clinical trial on Gardasil was only four years in duration In other words, Gardasil was never shown to prevent cervical cancer. Furthermore, in all clinical trials conducted by Merck the cervical intraepithelial neoplasia (CIN) 2/3 precancerous lesion was used as the efficacy endpoint for evaluating the Gardasil.
What is the problem with using the CIN 2/3 lesion as the standard for efficacy? First, if the marketing claim for Gardasil is that the vaccine “protects against cervical cancer” then cervical cancer should have been used as the endpoint for efficacy, not a surrogate marker such as a CIN 2/3 precancerous lesion. Second, in the natural course of cervical cancer, only a small fraction of the CIN 2 lesions will progress to CIN 3 lesions and only a small fraction of CIN 3 lesions will eventually progress to cervical cancer Furthermore, even CIN 3 lesions are heterogeneous (there are early small lesions and old advanced lesions and we do not know what proportion of the small lesions, which serve as clinical endpoints in current studies, would persist to become large, advanced CIN3 lesions). Therefore, in any female population (and that includes those who have undergone Gardasil clinical trials) there are many more CIN 2 lesions than a combination of CIN 3 lesions & cervical cancers. As a result, the vast majority of the “CIN 2/3 or worse” cases used for evaluation of efficacy, and listed in Merck‟s report to FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC Background Document on Gardasil HPV Quadrivalent Vaccine), must have been CIN 2 lesions.’ Lucija Tomljenovic, PhD
The CDC & NIAID openly admit to a “theoretical” risk of viral cross contamination, the presence of ‘endogenous retroviruses‘ (remnants of ancestral exogenous retroviral infections fixed in the germline DNA), ‘adventitious agents‘ (mutagenic viral strains) & ‘oncogenic agents’ (neoplasms or cancer), when harnessing (multiple) viruses in combination with heavy metals, tissue culture reagents, & stabilizer cocktails for vaccines.
‘Production of viral vaccines generally involves inoculation of a cell substrate (surface area/casing of cell) with a vaccine seed and purification of bulk product from these cells after a sufficient time for replication of the virus or production of vaccine proteins. Other raw materials (e.g., tissue culture reagents, stabilizers) may be added to the product at various stages of production. Thus, adventitious agents could theoretically enter a viral vaccine through any of these ingredients.
Close control of the vaccine manufacturing environment (by producing vaccines in sophisticated modern facilities), appropriate testing of the raw materials, and testing of both the bulk and final products can help ensure that adventitious agents have not entered the vaccine. Most vaccines are subjected to inactivation or purification steps that can reduce likelihood of contamination with adventitious agents.’ Centers for Disease Control
“Many novel vaccines are produced in animal cell substrates, and emerging infectious diseases may theoretically be transmitted from animals to humans through these vaccines. The challenge of identifying potential adventitious agents in vaccines closely parallels the challenge of identifying the agents causing particular emerging infectious diseases.’ CDC
“Because the influenza virus genome is segmented, coinfection of a single host cell with two or more different influenza viruses can result in a reassortment (shuffling) of their genetic material. The antigenic shift can lead to a pandemic if the resulting progeny virus contains an HA protein to which humans have no preexisting immunity, if it has an efficient replication-competent set of internal genes, and if it can readily spread from human to human.” Dr. Antony Fauci, director NIAID
It should come as no surprise that Gardasil, a composite of 4 viral strains of HPV, has been linked to a heightened risk of acquiring (an otherwise avoidable) cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma, and a 45% increased risk of precancerous lesions.
Gardasil contains Polysorbate 80 (also referred to as Tween 80; a type of detergent stabilizer commonly found in vaccines which is linked to infertility & severe allergic reactions (ie. anaphylaxis). Laboratory studies have found a correlation between Polysorbate 80 & ‘delayed” or stunted reproductive capacity.
‘Neonatal female rats were injected ip (0.1 ml/rat) with Tween 80 in 1, 5 or 10% aqueous solution on days 4-7 after birth. Treatment with Tween 80 accelerated maturation, prolonged the oestrus cycle, and induced persistent vaginal oestrus. The relative weight of the uterus and ovaries was decreased relative to the untreated controls. Squamous cell metaplasia of the epithelial lining of the uterus and cytological changes in the uterus were indicative of chronic oestrogenic stimulation. Ovaries were without corpora lutea, and had degenerative follicles.
http://www.ncbi.nlm.nih.gov/pubmed/8473002?dopt=Abstract “Polysorbate 80 was identified as the causative agent for the anaphylactoid reaction of nonimmunologic origin in the patient. Polysorbate 80 is a ubiquitously used solubilizing agent that can cause severe nonimmunologic anaphylactoid reactions.” Department of Dermatology, University of Aachen, Aachen, Germany
Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain (causes a blood/brain barrier breach) “Partial coverage was enough for Tween-80 coating to play a specific role in brain targeting of nanoparticles; concerned with the interaction between T-80 coating and brain micro-vessel endothelial cells. Therefore, the specific role of T-80 coating on nanoparticles in brain targeting was confirmed.” Department of Material Science and Engineering, Huazhong University of Science and Technology, China Study, 2003
The 3 doses required to complete the HPV vaccination regime are so intense, nurses administering the injections are advised to ask patients to lay down during the procedure. In many instances girls have fainted on the spot or gone into sudden seizures.
‘Considering that over 20 girls have experienced syncopal episodes sometimes combined with seizures and serious injuries, physicians should consider only giving GARDASIL when the patient is safely laying down on the examining table. Because there seems to be syncopal reactions up until 15 minutes after vaccination, patients should be asked to lie down for 15 minutes after receipt of GARDASIL.’
‘Fainting is common after injections, especially in pre-teens and teens. Falls that occur after someone faints can cause serious injuries, such as head injuries. To help prevent injuries, CDC and FDA recommends sitting or lying down for 15 minutes after vaccination.’
India recently called a halt to its own HPV mass vaccination campaign (Gardasil & Cervarix), after 6 girls died suddenly, shorty after receiving the shot; this on the heels of yet another vaccine scandal involving the sudden death of 4 Indian girls after injection with a new Pentavalent vaccine combining Hepatitis B, Haemophilus influenza type B (Hib), Diphtheria, Pertussis & Tetanus (DPT) – literally a tsunami of live viruses & heavy metals.
In light of all this evidence, the damning testimony of parents & teens around the world, Vaer’s own internal reports sponsored by the CDC & FDA, the adverse warnings provided by Vaccine Manufacturers Merck & GlaxoSmithKline in their package inserts, sound research indicating serious medical concerns on the front lines as to the efficacy & safety of this product, it seems almost inconceivable, but the Industry is pressing on with the campaign, now recommending “All girls and women age 11 through 26 years (as young as 9) should be vaccinated with 3 doses of HPV vaccine, given over a 6-month period” with the addition of “boys and men age 11 through 26 years (for genital warts).”
A mother knows better than anyone the real legacy of Gardasil & Cervarix, the betrayal of public trust, extending from the highest sectors of Government & the Vaccine Industry to the thousands of clinics & hospitals most families depend on, that has cut into the very heart of the community and devastated the lives of countless young women before reaching the prime of their lives.
“My daughter, 14 at the time of the one and only shot is still vomiting every day and has been in and out of hospitals for the last 6 months now. She was sick within 20 minutes of the vaccine and her little life has changed from cheer leader, track runner, soccer player, honor roll student and just plain vibrant, smart teenager to being fatigued, sick all the time and grades that are barely passing!
She is now one less, thanks to Merck. And the devastation this has caused our single mom home has been completely shocking. Only our faith in God and His Grace has gotten us this far. We recently moved back to Texas in hopes of finding a doctor at the Children’s Hospital that will look outside of the box. So many deal with the typical “If I can’t find it, then you must be faking” narcisistic doctors. Just keep us in your prayers. I don’t know how much longer we can go on like this.
I have met other moms with daughters that have the same exact symptoms. Comforting to not be alone, but scary because one has been vomiting every day for over a year now! I wish I had a dollar for every time I heard a mother say, “If I had only researched first!!” I could have afforded to stay in our home in Tennessee. Shame on you Merck. And shame on you FDA!” Laurie Dean-Smith
“My daughter was also one that was injured by this vaccine. Prior to receiving Gardasil, she was running six to ten miles daily, competing in state level meets and being recruited by colleges. However, within days of getting the shot she couldn’t breathe and had chest pains. Then nine days after this vaccine, she was admitted to ICU with inflammation and swelling around her heart. The doctor who admitted her said it was an allergic reaction to Gardasil!
Holly then went on to have dizziness, fatigue, muscle weakness, numbness and even temporary loss of vision, just to name a few. She became so ill she had to withdraw from school, so while her friends were going to football games and graduating, she was spending her days going back and forth to doctors, trying to find help. Before this she wanted to compete in the Olympics, now she wants to be able to finish high school.” Mariana Green
“My 18 yr old daughter’s life has been on hold since Feb 09. She received her 1st Gardasil shot in Aug 08, she complained of joint/muscle pain, I thought cheer-leading was working her too hard. Second shot in Nov 08, she was very fatigued, constantly complained of joint/muscle pain. She received her 3rd shot on Jan 2, 09. That shot pushed her body over the edge.
On Feb 2, she took her first trip in an ambulance to the ER with seizure like activity, struggling to breathe. Our lives were completely changed that day. We now have had FOUR ambulance rides, FIVE ER visits, FOUR hospital stays, a trip to Mayo Clinic, still no help. Drs deny the fact that Gardasil has these kinds of side effects. TEN months later, we are still trying to get our daughter fixed from the damage that Gardasil has done to her. IF Merck had listed joint/muscle pain as a side effect, I would not have taken her back for shots 2 & 3. The only side effect listed at that time was redness/soreness at shot sight.
We have spent Thousands of dollars trying to get her body back to where it was prior to Gardasil. Shame on me for NOT researching before vaccinating. But I trusted her DR, I trusted the FDA. Prior to Gardasil, my daughter was a very active A student, cheerleader, dancer and was very healthy. A nurse at the Dystonia place asked me if she had the shot after I described her symptoms. Obviously they had made the connection with other girls. All testing has been very expensive and NORMAL. Yet, there is nothing normal about her health.
Ten months later, she still has twitching, random jerking of her limbs, hair loss, very fatigued, extreme pain behind her eyes, very sensitive to light and noises, non epileptic seizures she has lost the ability to concentrate, difficult to test. I could go on and on. She should be enjoying her Senior Year, instead, she worries everyday about having a seizure at school. She is stressed over the fact that she cannot concentrate long enough to take the ACT/SAT tests.
She is a very positive girl, refuses to let Gardasil win, she struggles every day to try to make her life normal. All this because I wanted to help her by getting her the vaccine. Pretty much sucks to think you are doing the right thing and it turns out like this. Share this information with every mom you know> save other girls from suffering like mine has.” Robrich
‘Dr. Diane Harper, lead researcher in the development of two human papillomavirus vaccines, Gardasil and Cervarix, said the controversial drugs will do little to reduce cervical cancer rates and, even though they’re being recommended for girls as young as nine, there have been no efficacy trials in children under the age of 15. Dr. Harper, director of the Gynecologic Cancer Prevention Research Group at the University of Missouri, made these remarks during an address at the 4th International Public Conference on Vaccination which took place in Reston, Virginia on Oct. 2-4, 2009. Although her talk was intended to promote the vaccine, participants said they came away convinced the vaccine should not be received.
Excerpts from Dr. Harper’s speech (including additional comments made by her in 2007)
“70 percent of all HPV infections resolve themselves without treatment within a year. Within two years, the number climbs to 90 percent. Of the remaining 10 percent of HPV infections, only half will develop into cervical cancer, which leaves little need for the vaccine”
“There have been no efficacy trials (for Gardasil & Cervarix) in girls under 15 years.”
“Four out of five women with cervical cancer are in developing countries.”
“Even if we get the vaccine and continue PAP screening, we will not lower the rate of cervical cancer in the US.”
Re. Gardasil risk report, JAMA, 09/09 “The rate of serious adverse events is greater than the incidence rate of cervical cancer.”
Re. giving giving the vaccine to girls as young as 11 years-old, KPC News, 07 “is a great big public health experiment.”
Re. Media blackout on her steadfast opposition to school mandate forcing Gardasil on students, 07 “…but no one will print it.”
“It is silly to mandate vaccination of 11 to 12 year old girls. There also is not enough evidence gathered on side effects to know that safety is not an issue.”
Merck Package Insert: re. Limitations of GARDASIL Use and Effectiveness:
• GARDASIL does not eliminate the necessity for women to continue to undergo recommended cervical cancer screening.
• Recipients of GARDASIL should not discontinue anal cancer screening if it has been recommended by a health care provider.
• GARDASIL has not been demonstrated to provide protection against disease from vaccine and non-vaccine HPV types to which a person has previously been exposed through sexual activity.
• GARDASIL is not intended to be used for treatment of active external genital lesions; cervical, vulvar, vaginal, and anal cancers;
• GARDASIL has not been demonstrated to protect against diseases due to HPV types not contained in the vaccine. (1.3)
• Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL protects only against those vulvar, vaginal, and anal cancers caused by HPV.
• GARDASIL does not protect against genital diseases not caused by HPV.
• Vaccination with GARDASIL may not result in protection in all vaccine recipients.
CERVARIX:HPV [Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant] Suspension for Intramuscular Injection, Initial U.S. Approval: 2009
‘In the overall safety evaluation, 10 persons in the group that received quadrivalent HPV vaccine and seven persons in the placebo group died during the course of the trials. None of the deaths was considered to be vaccine related. Two deaths in the vaccine group and one death in the placebo group (Aluminum-containing or saline version) occurred within 15 days following vaccination. Seven deaths were attributed to motor-vehicle accidents (four in vaccine group and three in placebo group), three were caused by intentional overdose (nonstudy medications) or suicide (one in vaccine group and two in placebo group), two were attributed to pulmonary embolus or deep venous thrombosis (one each in vaccine and placebo group), two were attributed to sepsis, one case each attributed to cancer and arrhythmia (in vaccine group), and one case caused by asphyxia (placebo group).
Overall, 4.0%–4.9% of females who received quadrivalent HPV vaccine reported a temperature of >100°F (>38°C) after dose one, two, or three.’
‘Unfortunately, there were two vaccines, one which did not cover the genital warts virus at all – Cervarix – and a second vaccine – Gardasil – which covered the viruses that cause cervical cancer, HPV 16 and 18, but also types six and 11 which cause almost 100% of all genital warts in the UK. We naively thought at the time this was no contest, genital warts cost millions of pounds, as not only do types six and 11 cause warts but they also cause thousands of cervical smears to be classified as abnormal resulting in thousands of visits to GPs, gynaecology departments and sexual health clinics for wart treatments.
The Joint Vaccination Committee recommended HPV vaccination and said that if the vaccines were the same price, Gardasil should be chosen but if Cervarix was considerably cheaper then it might be the option. The reduction in cervical cancers wouldn’t be seen until 2025 whereas in a year of the vaccine program with Gardasil we would have started to see a reduction in genital warts and started saving millions of pounds not to mention reduction in workload and distressed patients.
In private we have all purchased Gardasil for our own children and advised colleagues to do the same.
It’s extraordinary that we are the only developed country in the world, apart from Holland, to have chosen Cervarix for the national programme. The Republic of Ireland did the maths and chose Gardasil. Australia, which was first country out of the blocks, had a vaccination programme for young women between the ages of 12-26 and within the year of their Gardasil vaccine program finishing, were already seeing a 47% reduction in genital wart presentation in young women with a corresponding 17% reduction in young men from herd immunity. A recent Australian study calculated that the only ‘danger to Australia in the future would be unvaccinated backpackers’ – Brits.
We, as consultants in sexual health, have been told to say nothing publicly that would damage the current vaccine program as the Cervarix vaccine has already been purchased. We have had to be circumspect in public but in private we have all purchased Gardasil for our own children and advised colleagues to do the same.’
http://www.bbc.co.uk/news/health-12417990
‘Drs. Colm O’Mahony and Steve Taylor insist that because Gardasil allegedly protects against genital warts as well as HPV, it is superior to Cervarix, which NHS currently administers to young girls. As long as Gardasil is the same price or cheaper than Cervarix, then NHS should use it, wrote the doctors. And if it is more expensive, then Cervarix is the next best option, they say.
But what is missing from their recommendations is the fact that Dr. O’Mahony has been on the advisory boards of both GSK and Merck, and has received “lecture fees” for his services. This clear conflict of interest may be the precise reason why no mention is made in the BBC piece about the countless thousands of young girls that have become debilitated or died from both Cervarix and Gardasil.’ Mke Adams, Health Ranger
CDC statement in defense of Gardasil & Cervarix: ‘Genital human papillomavirus (HPV) is the most common sexually transmitted virus in the United States. More than half of sexually active men and women are infected with HPV at some time in their lives. About 20 million Americans are currently infected, and about 6 million more get infected each year. HPV is usually spread through sexual contact. Most HPV infections don’t cause any symptoms, and go away on their own. But HPV can cause cervical cancer in women. Cervical cancer is the 2nd leading cause of cancer deaths among women around the world. In the United States, about 10,000 women get cervical cancer every year and about 4,000 are expected to die from it. HPV is also associated with several less common cancers, such as vaginal and vulvar cancers in women and other types of cancer in both men and women. It can also cause genital warts and warts in the throat. There is no cure for HPV infection, but some of the problems it causes can be treated.
HPV vaccine is important because it can prevent most cases of cervical cancer in females, if it is given before a person is exposed to the virus. Protection from HPV vaccine is expected to be long-lasting. But vaccination is not a substitute for cervical cancer screening. Women should still get regular Pap tests. The vaccine you are getting is one of two vaccines that can be given to prevent HPV. It may be given to both males and females. In addition to preventing cervical cancer, it can also prevent vaginal and vulvar cancer in females, and genital warts in both males and females. The other vaccine is given to females only, and only for prevention of cervical cancer.
This HPV vaccine has been used in the U.S. and around the world for several years and has been very safe. However, any medicine could possibly cause a serious problem, such as a severe allergic reaction. The risk of any vaccine causing a serious injury, or death, is extremely small. Life-threatening allergic reactions from vaccines are very rare. If they do occur, it would be within a few minutes to a few hours after the vaccination. Several mild to moderate problems are known to occur with HPV vaccine. These do not last long and go away on their own.
Reactions in the arm where the shot was given:
- Pain (about 8 people in 10)
- Redness or swelling (about 1 person in 4)
Fever:
- Mild (100° F) (about 1 person in 10)
- Moderate (102° F) (about 1 person in 65)
Other problems:
- Headache (about 1 person in 3) -Fainting. Brief fainting spells and related symptoms (such as jerking movements) can happen after any medical procedure, including vaccination. Sitting or lying down for about 15 minutes after a vaccination can help prevent fainting and injuries caused by falls. Tell your provider if the patient feels dizzy or light-headed, or has vision changes or ringing in the ears.’
As of September 30, 2010, there have been 56 U.S. reports of death among females who have received Gardasil. Thirty of these reports have been confirmed and 26 remain unconfirmed due to no identifiable patient information in the report such as a name and contact information to confirm the report. Confirmed reports are those that scientists have followed up on and have verified the claim. In the 30 reports confirmed, there was no unusual pattern or clustering to the deaths that would suggest that they were caused by the vaccine.’ CDC
‘In Britain, the government began administering the vaccine to school-aged girls last year, more than 2,000 patients reported some kind of adverse reaction including nausea, dizziness, blurred vision, convulsions, seizures and hyperventilation. Several reported multiple reactions, with 4,602 suspected side-effects recorded in total. The most tragic case involved a 14 year-old girl who dropped dead in the corridor of her school an hour after receiving the vaccination.’
‘Thousands of UK schoolgirls have suffered adverse reactions to the HPV Vaccine Cervavix (mandatory in schools). The analysis by the MHRA, drawn up this month, found 2,107 patients had reported some kind of suspected adverse reaction to Cervavix. Several reported multiple reactions, with 4,602 suspected side-effects recorded in total.
‘Teenage girl left brain-damaged after receiving cervical cancer jab’
Judicial Watch Investigates Side-Effects of HPV Vaccine
Related links:
Related Articles:
VRM: CDC-Gate Exposes A Trail of Fraud Behind Autism Studies
http://vaccineresistancemovement.org/?p=5743
VRM Live – 09/24/10: Vaccine Resistance Movement founder Joel Lord & activist/radio host Jesse Calhoun lay it all out tonite. Topics include the VRM Worldwide Autism Study, Scientific/Medical dictatorship, Natural Rights & Vaccine Industry fraud exposed. Special thanks to host Paul Mabelis.
http://www.blogtalkradio.com/empradio/2010/09/24/truth-to-power-thursday New Zealand is the latest country whose parents seem to be playing “wait and see” with the human papillomavirus (HPV) vaccine, Gardasil, joining the UK, France and Canada in delaying or refusing the drug for their children. Canterbury reports the lowest Gardasil vaccination rate in the country for girls aged 12 to 14, according to a recent report by The Press news agency. Parents are opting to wait until their daughters are older to consider the vaccine, the news reports, despite the fact the series of three shots is offered at no cost to them.
The American Academy of Pediatrics recently addedGardasil to its list of recommended vaccines for young men starting at age 9, for the prevention of genital warts. The vaccine, which protects against four strains of the human papillomavirus (HPV) already was recommended for girls by the age of 11 or 12 as a preventive measure against cervical cancer. However, parents should carefully weigh the pros and cons of this relatively new vaccine, which was approved by the FDA in 2006. Thousands ofadverse event reports are attached to the vaccine, and it has been linked to more than 50 deaths.
A recent news report says the prevalence and promotion of cervical cancer vaccines Gardasil andCervarix may cause women who are vaccinated to skip vital medical screening that could save their lives. According to the story in a recent edition of Australia’s News Limited publication, The Advertiser, studies indicate women believe receiving the vaccine makes annual Pap smears unnecessary. However, because cervical cancervaccines only protect against a few of the hundreds of types of human papillomavirus (HPV), Pap smears are still a very important part of being protected against cervical cancer. Read the rest of this entry »
Health officials in the Candadian province of London, Ontario, said more than half of girls of qualifying age are opting not to receive the Gardasil vaccine. The study, which comes out of the London-Middlesex area, said only about 45 percent of eighth-grade girls decided to receive the three-dose vaccination against theHuman Papillomavirus (HPV), which is paid for by the federal government. HPV has been identified to cause cervical cancer. Read the rest of this entry »
Government health agencies in France and the United Kingdom are cracking down on the manufacturers ofHPV vaccines Gardasil and Cervarix, saying the companies are falsely advertising their products. According to a report in the American Chronicle, vaccine watchdog organization SANE VAX has been following the investigation of problems with the advertisements, which have resulted in the ads being banned in France and removed in the UK and India. Read the rest of this entry »
A coroner in the Canadian province of Quebec is expressing concern about possible unknown side effects related to the HPV vaccine, Gardasil. The medical examiner became worried after examining the body of a 14-year-old girl, who died after receiving her second dose of the vaccine, which is used to protect girls and young women from the sexually transmitted human papillomavirus, which can cause cervical cancer.
The U.S. Food and Drug Administration (FDA) has approved the use of the Gardasil vaccine for the prevention of anal cancer. Previously, the drug was approved only for use in girls and young women, for the prevention of cervical cancer. Gardasil targets the human papillomavirus (HPV), a sexually transmitted virus that can cause cervical cancer. Recent studies have also show the virus can cause anal cancer.
An advisory panel to the U.S. Food & Drug Administration (FDA) is expected to decide by the end of the year whether it will recommend expanding the use of the HPV vaccine, Gardasil, for use in boys and young men. The drug, which targets the Human Papillomavirus and is currently recommended for use in girls and young women for the prevention of cervical cancer, is currently approved, but not recommended, for young men to prevent genital warts.
Recently, WTVR CBS-6 News in Richmond, Virginia, brought viewers a troubling report of serious adverse events and 16 deaths linked to theGardasil vaccine. The vaccine, which is intended to prevent four types ofhuman papillomavirus (HPV) that cause cervical cancer, is required for girls in Virginia prior to entering the sixth grade unless their parents object. The story, which is based on a new FDA adverse event report obtained by the government watchdog group Judicial Watch, sparked debate in the area and is generating interest nationwide.
Parents in Virginia are worried following the release of a new report that links the Gardasil vaccine to 16 deaths and nearly 4,000 adverse events. Currently, the vaccine, which protects against four types of human papillomavirus (HPV) linked to cervical cancer, is required for girls in the state prior to entering the sixth grade, unless parents object.
